IL180229A0 - PROTEIN COMPLEX CONTAINING A HEMAGGLUTININ AND A POLYPEPTIDE-Hc-CONJUGATE AND METHODS FOR THE PREPARATION THEREOF - Google Patents

PROTEIN COMPLEX CONTAINING A HEMAGGLUTININ AND A POLYPEPTIDE-Hc-CONJUGATE AND METHODS FOR THE PREPARATION THEREOF

Info

Publication number
IL180229A0
IL180229A0 IL180229A IL18022906A IL180229A0 IL 180229 A0 IL180229 A0 IL 180229A0 IL 180229 A IL180229 A IL 180229A IL 18022906 A IL18022906 A IL 18022906A IL 180229 A0 IL180229 A0 IL 180229A0
Authority
IL
Israel
Prior art keywords
hemagglutinin
conjugate
polypeptide
preparation
methods
Prior art date
Application number
IL180229A
Other languages
English (en)
Original Assignee
Biotecon Therapeutics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotecon Therapeutics Gmbh filed Critical Biotecon Therapeutics Gmbh
Publication of IL180229A0 publication Critical patent/IL180229A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IL180229A 2004-07-22 2006-12-21 PROTEIN COMPLEX CONTAINING A HEMAGGLUTININ AND A POLYPEPTIDE-Hc-CONJUGATE AND METHODS FOR THE PREPARATION THEREOF IL180229A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004035606A DE102004035606A1 (de) 2004-07-22 2004-07-22 Carrier für Arzneimittel zur Gewinnung der oralen Bioverfügbarkeit
PCT/DE2005/001290 WO2006010360A2 (de) 2004-07-22 2005-07-22 Carrier für arzneimittel zur gewinnung der oralen bioverfügbarkeit

Publications (1)

Publication Number Publication Date
IL180229A0 true IL180229A0 (en) 2007-07-04

Family

ID=35482323

Family Applications (1)

Application Number Title Priority Date Filing Date
IL180229A IL180229A0 (en) 2004-07-22 2006-12-21 PROTEIN COMPLEX CONTAINING A HEMAGGLUTININ AND A POLYPEPTIDE-Hc-CONJUGATE AND METHODS FOR THE PREPARATION THEREOF

Country Status (13)

Country Link
EP (1) EP1768701A2 (de)
JP (1) JP2008506724A (de)
KR (1) KR20070047786A (de)
CN (1) CN101340932A (de)
AU (1) AU2005266739A1 (de)
BR (1) BRPI0513715A (de)
CA (1) CA2574124A1 (de)
DE (1) DE102004035606A1 (de)
IL (1) IL180229A0 (de)
MX (1) MX2007000421A (de)
NO (1) NO20070775L (de)
RU (1) RU2006147284A (de)
WO (1) WO2006010360A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008169166A (ja) * 2007-01-14 2008-07-24 Tokyo Univ Of Agriculture & Technology 糖結合性ポリペプチド、複合材料、及び薬剤送達システム
JP2009132686A (ja) * 2007-10-26 2009-06-18 Okayama Univ ボツリヌス毒素由来のポリペプチド及びボツリヌス毒素の検出方法
WO2009131435A1 (en) * 2008-04-23 2009-10-29 Erasmus University Medical Center Rotterdam Linker containing bungarotoxin and a binding peptide
WO2011075500A2 (en) * 2009-12-18 2011-06-23 Allergan, Inc. Stabilization of therapeutic agents to facilitate administration
CN103875314B (zh) 2011-07-15 2016-03-16 Nxp股份有限公司 谐振变换器的控制方法及控制器
CN108137654A (zh) * 2015-05-15 2018-06-08 内布拉斯加大学董事会 适用于将分子递送进入选定细胞的工程改造的肉毒梭菌毒素
CN115894719B (zh) * 2022-11-24 2023-10-20 武汉禾元生物科技股份有限公司 一种人血清白蛋白胰岛素偶联物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8914984D0 (en) * 1989-06-29 1989-08-23 Animal Health Inst Nucleotide sequences
US20030202989A1 (en) * 1995-12-13 2003-10-30 R. John Collier Use of toxin peptides and/or affinity handles for delivering compounds into cells
GB9617671D0 (en) * 1996-08-23 1996-10-02 Microbiological Res Authority Recombinant toxin fragments
GB9824282D0 (en) * 1998-11-05 1998-12-30 Microbiological Research Agenc Delivery of superoxide dismutase to neuronal cells
DE19856052A1 (de) * 1998-12-04 2000-06-08 Deutsches Krebsforsch Konjugat zur Anreicherung in neuronalen Zellen
US6776990B2 (en) * 1999-04-08 2004-08-17 Allergan, Inc. Methods and compositions for the treatment of pancreatitis
US6500436B2 (en) * 2000-01-19 2002-12-31 Allergan, Inc. Clostridial toxin derivatives and methods for treating pain
US6641820B1 (en) * 2000-01-19 2003-11-04 Allergan, Inc. Clostridial toxin derivatives and methods to treat pain
US6670322B2 (en) * 2000-06-01 2003-12-30 Wisconsin Alumni Research Foundation Method of targeting pharmaceuticals to motor neurons
DE10035156A1 (de) * 2000-07-19 2002-02-07 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Proteinkomplex als Vehikel für oral verfügbare Protein-Arzneimittel
US20040220100A1 (en) * 2000-07-21 2004-11-04 Essentia Biosystems, Inc. Multi-component biological transport systems
WO2003061694A1 (en) * 2001-05-10 2003-07-31 Seattle Genetics, Inc. Immunosuppression of the humoral immune response by anti-cd20 antibodies
GB0112687D0 (en) * 2001-05-24 2001-07-18 Microbiological Res Authority Pharmaceutical use of secreted bacterial effector proteins
WO2003101484A1 (en) * 2002-05-31 2003-12-11 Thomas Jefferson University Compositions and methods for transepithelial molecular transport
JP2007070225A (ja) * 2003-07-25 2007-03-22 Yukako Fujinaga クロストリジウム属菌由来成分を含む医薬製剤
US20050129677A1 (en) * 2003-12-10 2005-06-16 Shengwen Li Lipid rafts and clostridial toxins

Also Published As

Publication number Publication date
BRPI0513715A (pt) 2008-05-13
WO2006010360A2 (de) 2006-02-02
AU2005266739A1 (en) 2006-02-02
EP1768701A2 (de) 2007-04-04
RU2006147284A (ru) 2008-08-27
DE102004035606A1 (de) 2006-03-30
WO2006010360A3 (de) 2007-12-27
MX2007000421A (es) 2007-03-28
JP2008506724A (ja) 2008-03-06
KR20070047786A (ko) 2007-05-07
NO20070775L (no) 2007-04-18
CA2574124A1 (en) 2006-02-02
CN101340932A (zh) 2009-01-07

Similar Documents

Publication Publication Date Title
EP1830956A4 (de) Katalytisch wirksame materialien und herstellungsverfahren dafür
IL187317A0 (en) A polypeptide complex and pharmaceutical compositions containing the same
HK1137439A1 (en) Fused pyrrolocarbazoles and methods for the preparation thereof
EP1972251A4 (de) Kapselbehälter und verabreichungsverfahren damit
EP1809259A4 (de) Pharmazeutische zubereitungen mit geringerem missbrauchspotential
ZA200705086B (en) Catalytic materials and method for the preparation thereof
IL182771A0 (en) A thymus-specific protein
IL180229A0 (en) PROTEIN COMPLEX CONTAINING A HEMAGGLUTININ AND A POLYPEPTIDE-Hc-CONJUGATE AND METHODS FOR THE PREPARATION THEREOF
GB0417887D0 (en) Protein
EP1725584A4 (de) Neues, mit phytochrom wechselwirkendes protein und verwendung davon
IL177580A0 (en) Sulfonyloxy derivatives and methods for the preparation thereof
GB0401882D0 (en) Protein
GB0416035D0 (en) Protein
GB0710292D0 (en) Cosmetic agents and methods for the preparation thereof
HK1082770A1 (en) Supter-antigen fusion proteins and the use thereof
IL183334A0 (en) Activated labeling reagents and methods for preparing and using the same
GB0403979D0 (en) Protein
GB0413604D0 (en) Protein
GB0402088D0 (en) Protein
GB0402662D0 (en) Protein
GB0402811D0 (en) Protein
GB0403142D0 (en) Protein
GB0403742D0 (en) Protein
GB0400784D0 (en) Protein
GB0404929D0 (en) Protein